Literature DB >> 11447771

Hyperalgesic effect of intrathecally administered interleukin-1 in rats.

M Falchi1, F Ferrara, C Gharib, B Dib.   

Abstract

The present study demonstrates that intrathecal injection of interleukin-1 (IL-1) in rats at a dose of 50 pg or 500 pg induced a significant hyperalgesic effect in the hot-plate test. The hyperalgesia or the altered nociceptive responses were not considered to be the result of sensitization to the hot plate, since the nociceptive alteration caused by intrathecal administration of IL-1 stopped after 20 min. The results suggest that IL-1 can affect pain responsiveness in a dose-dependent manner and that it is able to modulate neuronal functions. Taken together, our findings and the data from the literature suggest that IL-1-induced hyperalgesia is related not only to the route of administration but also to the algesia testing method used.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447771

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  12 in total

1.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

2.  Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors.

Authors:  Kohei Shimizu; Wei Guo; Hu Wang; Shiping Zou; Stacey C LaGraize; Koichi Iwata; Feng Wei; Ronald Dubner; Ke Ren
Journal:  Mol Pain       Date:  2009-12-21       Impact factor: 3.395

3.  Glial activation and segmental upregulation of interleukin-1beta (IL-1beta) in the rat spinal cord after surgical incision.

Authors:  Di Fu; Qulian Guo; Yuhang Ai; Hongwei Cai; Jianqin Yan; Ruping Dai
Journal:  Neurochem Res       Date:  2006-05-03       Impact factor: 3.996

4.  Endogenous interleukin-1β in neuropathic rats enhances glutamate release from the primary afferents in the spinal dorsal horn through coupling with presynaptic N-methyl-D-aspartic acid receptors.

Authors:  Xisheng Yan; Han-Rong Weng
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

5.  Microinjection of IL-1β into the trigeminal transition zone produces bilateral NMDA receptor-dependent orofacial hyperalgesia involving descending circuitry.

Authors:  K Shimizu; Bryan Chai; Stacey C Lagraize; F Wei; R Dubner; K Ren
Journal:  Open Pain J       Date:  2009-01-01

6.  Reactive astrocytes in glial scar attract olfactory ensheathing cells migration by secreted TNF-alpha in spinal cord lesion of rat.

Authors:  Zhida Su; Yimin Yuan; Jingjing Chen; Li Cao; Yanling Zhu; Liang Gao; Yang Qiu; Cheng He
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

Review 7.  Postoperative pain management and proinflammatory cytokines: animal and human studies.

Authors:  Yehuda Shavit; Keren Fridel; Benzion Beilin
Journal:  J Neuroimmune Pharmacol       Date:  2006-09-29       Impact factor: 4.147

8.  Effect of interleukin-1beta on spinal cord nociceptive transmission of normal and monoarthritic rats after disruption of glial function.

Authors:  Luis Constandil; Alejandro Hernández; Teresa Pelissier; Osvaldo Arriagada; Karla Espinoza; Hector Burgos; Claudio Laurido
Journal:  Arthritis Res Ther       Date:  2009-07-08       Impact factor: 5.156

9.  Interleukin 1β inhibition contributes to the antinociceptive effects of voluntary exercise on ischemia/reperfusion-induced hypersensitivity.

Authors:  Jessica L Ross; Luis F Queme; Jordan E Lamb; Kathryn J Green; Zachary K Ford; Michael P Jankowski
Journal:  Pain       Date:  2018-02       Impact factor: 7.926

10.  Neuropathic Pain Phenotype Does Not Involve the NLRP3 Inflammasome and Its End Product Interleukin-1β in the Mice Spared Nerve Injury Model.

Authors:  Verdad Curto-Reyes; Guylène Kirschmann; Marie Pertin; Stephan K Drexler; Isabelle Decosterd; Marc R Suter
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.